acrolein has been researched along with Cardiomegaly in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Guo, W; Lu, R; Qian, D; Shan, X; Tian, J; Wang, S; Xu, M; Zhang, C; Zhao, P | 1 |
1 other study(ies) available for acrolein and Cardiomegaly
Article | Year |
---|---|
Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway.
Topics: Acrolein; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; MAP Kinase Signaling System; Mice; Myocytes, Cardiac; Phenylephrine; Rats; Ryanodine Receptor Calcium Release Channel | 2022 |